Q13.5
Blue sclera
Clinical Classification Guidelines
Medical Intelligence & Overview
Blue sclera is a condition where the sclera, the white outer layer of the eye, appears bluish or grayish instead of its usual white color. This change results from structural alterations in the sclera, often making the underlying choroid more visible. Although it can be a benign characteristic, in some cases, blue sclera indicates underlying health conditions requiring medical attention. Recognizing the signs of blue sclera can help differentiate between harmless variations and symptoms of more serious disorders.
Causes & Symptoms
Clinical Causes: Genetic conditions such as osteogenesis imperfecta Ehlers-Danlos syndrome Marfan syndrome Scleritis or other inflammatory eye conditions Certain connective tissue disorders Vitamin D deficiency or rickets
Key Symptoms: Bluish or grayish tint to the sclera Possible eye discomfort or sensitivity Changes in vision (less common) Signs related to underlying diseases, such as bone deformities in osteogenesis imperfecta In cases associated with systemic conditions, additional symptoms like joint hypermobility or fragile bones
Diagnostic & Treatment
Diagnosis Path: Diagnosis of blue sclera primarily involves a thorough eye examination by an ophthalmologist. The clinician will inspect the sclera for color changes and assess for associated symptoms. Healthcare providers may also review the individual's medical history and look for signs of underlying systemic diseases. Additional tests might include genetic testing or blood work if a hereditary condition such as osteogenesis imperfecta is suspected. Imaging studies are rarely necessary solely for blue sclera but may be used to evaluate associated systemic features.
Treatment Protocols: Treatment of blue sclera depends on its underlying cause. In many cases, blue sclera itself does not require treatment if it is an isolated congenital feature or benign variation. Managing associated conditions involves:
Clinical Advice & FAQs
Billing Guidance
Is Q13.5 a billable ICD-10 code?
Yes, Q13.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q13.5?
Clinical documentation must specify the nature of Blue sclera and any associated comorbidities for accurate reporting.
Cite this Clinical Reference